FeesSafety
Pluang+

IBM unveils Nighthawk r3 quantum processor with 520 qubits, enabling 10,000 quantum operations for complex computing.

Market News
11 Nov 2026, 14:00 WIB
PRNewsWire
View Source
Bullish
IBM unveils Nighthawk r3 quantum processor with 520 qubits, enabling 10,000 quantum operations for complex computing.

IBM announced its new Quantum Nighthawk r3 processor, designed to execute 10,000 quantum operations on 520 qubits, allowing for larger and more complex quantum computations. Building on the success of Nighthawk r2, which delivered up to 19x speed improvements, the r3 will support advanced quantum workloads and is planned to be linked into a 1,040-qubit system by 2027. This advancement enhances IBM's roadmap toward fault-tolerant quantum computing and integrates quantum with classical computing on the IBM Quantum Platform, enabling faster and more accurate scientific and industrial applications.

IBM Quantum Nighthawk's development toward a 1,040-qubit system by 2027 provides context for technology sector performance. For readers following Technology-sector US stocks on Pluang, here is the market snapshot as of Nov 11, 2026 18:02 WIB: out of 150 stocks, 105 rose and 42 fell. Notable movers include CIFR at USD 7.05 (+7.96%), STX at USD 540.50 (+7.75%), and DOCN at USD 85.58 (+7.62%).

More News

NRx Pharmaceuticals launches U.S.-made preservative-free ketamine to address long-standing shortage.

NRx Pharmaceuticals launches U.S.-made preservative-free ketamine to address long-standing shortage.

NRx Pharmaceuticals has begun selling a new preservative-free ketamine made in the U.S., addressing a shortage that has persisted since 2018. This ketamine uses innovative blow-fill-seal technology, eliminating the preservative benzethonium chloride,...

Market News
Bullish
16 minutes ago
FLSmidth sets financial report and AGM dates for 2027, highlighting sustainability goals.

FLSmidth sets financial report and AGM dates for 2027, highlighting sustainability goals.

FLSmidth & Co. A/S announced its financial calendar for 2027, including key dates for the annual report, interim financial reports, and the annual general meeting. The company emphasizes its commitment to sustainability with its MissionZero goal to a...

Company Fundamentals
Neutral
1 hour ago
Dimensional Fund Advisors discloses 1.27% stake in Prologis Inc as of November 2026

Dimensional Fund Advisors discloses 1.27% stake in Prologis Inc as of November 2026

Dimensional Fund Advisors Ltd. has filed a Form 8.3 disclosure revealing it holds a 1.27% stake in Prologis Inc, totaling 12,054,886 shares as of November 10, 2026. This disclosure is part of regulatory requirements under the Takeover Code, indicatin...

Market News
Neutral
2 hours ago
Dimensional Fund Advisors discloses 1.61% stake in DCC Energy shares as of Nov 10, 2026

Dimensional Fund Advisors discloses 1.61% stake in DCC Energy shares as of Nov 10, 2026

Dimensional Fund Advisors Ltd. has filed a disclosure showing it holds a 1.61% stake in DCC Energy plc's ordinary shares as of November 10, 2026. The firm sold 42,998 shares recently at a price of £64.5585 each. This disclosure is part of regulatory ...

Market News
Neutral
2 hours ago
Novo Nordisk pledges $200M over 10 years to boost diabetes care in low-income countries

Novo Nordisk pledges $200M over 10 years to boost diabetes care in low-income countries

Novo Nordisk has committed $200 million to the World Diabetes Foundation for 2027–2036 to enhance diabetes prevention and care in low- and middle-income countries. This funding aims to improve equitable access to diabetes services in underserved comm...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App